Tech Company Financing Transactions
Ratio Therapeutics Funding Round
Ratio Therapeutics, based in Boston, secured $70 million in investment from Bristol Myers Squibb, Catalio Capital Management and Duquesne Capital Management.
Transaction Overview
Company Name
Announced On
8/3/2026
Transaction Type
Venture Equity
Amount
$70,000,000
Round
Series C
Investors
Proceeds Purpose
The company intends to use the funds to advance its ongoing ATLAS study evaluating its lead radiotherapeutic asset [Ac-225]RTX-2358 in advanced sarcomas, move its next-generation RLT candidate into the clinic, expand its discovery pipeline into new oncology targets, strengthen its proprietary technology, and scale its manufacturing capabilities.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
77 Sleeper St
Boston, MA 02210
USA
Boston, MA 02210
USA
Phone
Undisclosed
Website
Email Address
Overview
A discovery through early clinical phase pharmaceutical company, Ratio Therapeutics employs a suite of innovative technologies to develop best-in-class targeted radiotherapeutics for the treatment of cancer. Ratio Therapeutics' Trillium� targeting scaffold combines pharmacokinetic modulation with best-in-class chelation technology to create proprietary small molecule targeting agents to attack a broad array of cancer targets. Our compounds accommodate imaging and therapeutic radioisotopes, ie "theranostics". The tunable nature of our platform combined with small-scale imaging trials in patients results in accelerated, de-risked compound selection.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Jack Hoppin
Chief Financial Officer
Reed Malleck
Chief Operating Officer
Shawn Hillier
Chief Scientific Officer
John Babich
Chief Technical Officer
Matthias Friebe
Browse more venture capital transactions:
Prev: 8/3/2026: June.ai venture capital transaction
Next: 8/3/2026: Fixxly venture capital transaction
Share this article
About Our Venture Capital Transactions Database
We do our best to report on all VC transactions involving tech companies. VC transactions reported here are sourced from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs